Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Coinbase
COIN
|
+$862M |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$853M |
| 3 |
Meta Platforms (Facebook)
META
|
+$641M |
| 4 |
Intel
INTC
|
+$547M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$518M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$3.09B |
| 2 |
Tesla
TSLA
|
+$1.13B |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$756M |
| 4 |
Dell
DELL
|
+$641M |
| 5 |
ProShares UltraPro QQQ
TQQQ
|
+$631M |
Sector Composition
| 1 | Technology | 16.48% |
| 2 | Consumer Discretionary | 10.12% |
| 3 | Financials | 9.46% |
| 4 | Healthcare | 7.62% |
| 5 | Communication Services | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
5351
Coya Therapeutics
COYA
$95M
| $74.3K | ﹤0.01% |
+12,961
| New | +$74.3K |
|
5352
Safety Shot
SHOT
$76.1M
| $73.6K | ﹤0.01% |
102,267
+81,720
| +398% | +$58.8K |
|
|
IVAC
5353
DELISTED
Intevac Inc
IVAC
| $73.5K | ﹤0.01% |
21,615
-7,930
| -27% | -$27K |
|
|
GAU
5354
Galiano Gold
GAU
$659M
| $73.3K | ﹤0.01% |
59,555
+2,249
| +4% | +$2.77K |
|
5355
Heron Therapeutics
HRTX
$227M
| $73.2K | ﹤0.01% |
47,827
-284,299
| -86% | -$435K |
|
|
NBTX
5356
Nanobiotix
NBTX
$449M
| $72.9K | ﹤0.01% |
+23,283
| New | +$72.9K |
|
5357
Inovio Pharmaceuticals
INO
$121M
| $72.7K | ﹤0.01% |
39,704
+21,512
| +118% | +$39.4K |
|
5358
Nuveen Credit Strategies Income Fund
JQC
$743M
| $72K | ﹤0.01% |
12,652
-11,505
| -48% | -$65.5K |
|
5359
Copel
ELP
$7.09B
| $70.7K | ﹤0.01% |
11,923
-197,305
| -94% | -$1.17M |
|
5360
Wrap Technologies
WRAP
$97.6M
| $70.5K | ﹤0.01% |
+33,250
| New | +$70.5K |
|
5361
Cue Biopharma
CUE
$56.9M
| $69.5K | ﹤0.01% |
63,767
+37,832
| +146% | +$41.2K |
|
|
EDAP
5362
EDAP TMS
EDAP
$90.1M
| $69.3K | ﹤0.01% |
+31,361
| New | +$69.3K |
|
5363
Fortress Biotech
FBIO
$106M
| $69.2K | ﹤0.01% |
+34,159
| New | +$69.2K |
|
5364
Laser Photonics
LASE
$34.8M
| $68.8K | ﹤0.01% |
11,909
-23,476
| -66% | -$136K |
|
5365
Puma Biotechnology
PBYI
$234M
| $68.6K | ﹤0.01% |
22,480
-9,649
| -30% | -$29.4K |
|
5366
BlackRock Enhanced International Dividend Trust
BGY
$526M
| $68.4K | ﹤0.01% |
+12,883
| New | +$68.4K |
|
|
CHMI
5367
Cherry Hill Mortgage Investment Corp
CHMI
$109M
| $68.2K | ﹤0.01% |
+25,840
| New | +$68.2K |
|
5368
Mural Oncology
MURA
$35.9M
| $68K | ﹤0.01% |
+21,117
| New | +$68K |
|
5369
VYNE Therapeutics
VYNE
$7.8M
| $68K | ﹤0.01% |
+20,286
| New | +$68K |
|
5370
Smith Micro Software
SMSI
$14.8M
| $67.4K | ﹤0.01% |
51,480
+33,784
| +191% | +$44.3K |
|
5371
SuRo Capital
SSSS
$217M
| $67.3K | ﹤0.01% |
+11,452
| New | +$67.3K |
|
5372
Anixa Biosciences
ANIX
$116M
| $66.9K | ﹤0.01% |
+28,846
| New | +$66.9K |
|
5373
Epsilon Energy
EPSN
$117M
| $66.8K | ﹤0.01% |
+10,754
| New | +$66.8K |
|
5374
Cibus
CBUS
$72M
| $66.7K | ﹤0.01% |
+23,990
| New | +$66.7K |
|
5375
TTEC Holdings
TTEC
$173M
| $66.6K | ﹤0.01% |
13,346
-32,300
| -71% | -$161K |
|